As filed with the Securities and Exchange Commission on January 6, 2026. Registration Statement No. 333-292131 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 __________________________________ AMENDMENT NO. 1 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 __________________________________ Invea Therapeutics, Inc. (Exact name of registrant as specified in its charter) __________________________________ Delaware 2834 87-3198325 (State or other jurisdiction of inc ...

Registration Statement No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 __________________________________ FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 __________________________________ Invea Therapeutics, Inc. (Exact name of registrant as specified in its charter) __________________________________ (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) Delaware 2834 87-3198325 (I.R.S. Emplo ...

TABLE OF CONTENTS As filed with the Securities and Exchange Commission confidentially on October 20, 2023. Registration Statement No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Invea Therapeutics, Inc. (Exact name of registrant as specified in its charter) 2834 (Primary Standard Industrial Classification Code Number) 87-3198325 (I.R.S. Employer 2614 Boston Post Road, Suite 33AR Guilford, Connecticut 06437 (203 ...